Ken Omura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ken Omura has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Hiroyuki Harada
Department of Oral and Maxillofacial Surgical Oncology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan
11 shared publications - Hiroaki Shimamoto
Oral and Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8549, Japan.
5 shared publications - Hirofumi Tomioka
Department of Oral and Maxillofacial Surgical Oncology, Division of Health Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-Ku, Tokyo 113-8510, Japan
4 shared publications - Kae Tanaka
Department of Oral and Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.
4 shared publications - Kou Kayamori
Department of Oral Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
3 shared publications Norihiko Okada
3 shared publications
Latest Publications
- Open Access
- 8 December 2015
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 9 (1) , 1-5
Massive odontoameloblastoma arising in the maxilla: a case report
- 8 December 2015
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 9 (1) , 1-5
Open AccessMassive odontoameloblastoma arising in the maxilla: a case report
- 17 January 2015
- Published by Springer Nature
- p. 221-230
Management of the Neck
- 1 January 2015
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 236 (3) , 193-198
Chronic Sclerosing Sialadenitis of the Submandibular Gland as the Initial Symptom of IgG4-Related Disease: A Case Report
Immunoglobulin G4-related disease (IgG4-RD) is a systemic condition accompanied by tumefactive lesions, dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, storiform fibrosis in various organs, and, frequently, elevated serum IgG4 levels. Chronic sclerosing sialadenitis (also termed Küttner's tumor) is thought to be a lesion of IgG4-RD; thus, IgG4-related sialadenitis may be the initial symptom of IgG4-RD. We herein report a 64-year-old Japanese female with IgG4-related chronic sclerosing sialadenitis of the right submandibular gland and retroperitoneal fibrosis, who subsequently developed tubulointerstitial nephritis and pancreatitis. She was referred to our Department for treatment of swelling of the right submandibular gland; preoperative imaging studies suggested a malignant tumor. We extirpated the submandibular glands bilaterally and diagnosed IgG4-related chronic sclerosing sialadenitis pathologically. Subsequently, the patient's serum IgG4 concentration increased, and lesions in the retroperitoneum, kidney, and pancreas were confirmed by imaging. Although the radiological characteristics of these lesions mimicked malignancy, steroid treatment was commenced based on the pathology of the submandibular gland and elevated serum IgG4 level. This caused the lesions to disappear, indicating that the patient had experienced IgG4-related retroperitoneal fibrosis, tubulointerstitial nephritis, and pancreatitis. No relapse was detected for 4 years 8 months after surgery. A pathological diagnosis is crucial to exclude the possibility of malignancy and to make treatment decisions when lesions are evident in other organs. In addition, periodic evaluation of the serum IgG4 concentration and imaging of the whole body are warranted in long-term follow-up.
- 1 January 2015
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 236 (3) , 193-198
Chronic Sclerosing Sialadenitis of the Submandibular Gland as the Initial Symptom of IgG4-Related Disease: A Case Report
Immunoglobulin G4-related disease (IgG4-RD) is a systemic condition accompanied by tumefactive lesions, dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, storiform fibrosis in various organs, and, frequently, elevated serum IgG4 levels. Chronic sclerosing sialadenitis (also termed Küttner's tumor) is thought to be a lesion of IgG4-RD; thus, IgG4-related sialadenitis may be the initial symptom of IgG4-RD. We herein report a 64-year-old Japanese female with IgG4-related chronic sclerosing sialadenitis of the right submandibular gland and retroperitoneal fibrosis, who subsequently developed tubulointerstitial nephritis and pancreatitis. She was referred to our Department for treatment of swelling of the right submandibular gland; preoperative imaging studies suggested a malignant tumor. We extirpated the submandibular glands bilaterally and diagnosed IgG4-related chronic sclerosing sialadenitis pathologically. Subsequently, the patient's serum IgG4 concentration increased, and lesions in the retroperitoneum, kidney, and pancreas were confirmed by imaging. Although the radiological characteristics of these lesions mimicked malignancy, steroid treatment was commenced based on the pathology of the submandibular gland and elevated serum IgG4 level. This caused the lesions to disappear, indicating that the patient had experienced IgG4-related retroperitoneal fibrosis, tubulointerstitial nephritis, and pancreatitis. No relapse was detected for 4 years 8 months after surgery. A pathological diagnosis is crucial to exclude the possibility of malignancy and to make treatment decisions when lesions are evident in other organs. In addition, periodic evaluation of the serum IgG4 concentration and imaging of the whole body are warranted in long-term follow-up.
- 1 April 2014
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 19 (3) , 423-430
Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma
The primary treatment modality of oral cancer is generally determined according to the stage of the disease, with surgical treatment remaining the mainstay of multimodal treatment. When selecting the treatment, many factors are taken into consideration, and the treatment should be tailored individually to the patient’s needs and consider the quality of life as well as the survival of the patient. Early-stage disease is primarily managed with surgery or brachytherapy without functional morbidity, whereas for advanced-stage disease multidisciplinary treatment is recommended, not only for enhanced survival but also for improved quality of life. After resection of large primary tumors, reconstructive surgery is required. Free tissue transfer currently represents one of the most popular and reliable techniques for oral reconstruction. For cN0 neck, elective neck dissection is recommended when the risk of occult metastases is >20 %, when the neck is entered either for resection of the primary tumor or for reconstruction, or when the patient is unlikely to return for a close follow-up. Sentinel node biopsy is performed investigationally. Modified radical neck dissection is the gold standard for cN+ neck. For patients with multiple node metastases or extracapsular spread, postoperative radiotherapy or chemoradiotherapy is recommended, with the lymph nodes situated outside the confines of the radical neck dissection, such as the lingual and retropharyngeal nodes, receiving considerable attention. Targeted therapy for oral cancer is still a relatively new concept, and more studies are needed to confirm the clinical effectiveness of these drugs.
- 1 April 2014
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 19 (3) , 423-430
Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma
The primary treatment modality of oral cancer is generally determined according to the stage of the disease, with surgical treatment remaining the mainstay of multimodal treatment. When selecting the treatment, many factors are taken into consideration, and the treatment should be tailored individually to the patient’s needs and consider the quality of life as well as the survival of the patient. Early-stage disease is primarily managed with surgery or brachytherapy without functional morbidity, whereas for advanced-stage disease multidisciplinary treatment is recommended, not only for enhanced survival but also for improved quality of life. After resection of large primary tumors, reconstructive surgery is required. Free tissue transfer currently represents one of the most popular and reliable techniques for oral reconstruction. For cN0 neck, elective neck dissection is recommended when the risk of occult metastases is >20 %, when the neck is entered either for resection of the primary tumor or for reconstruction, or when the patient is unlikely to return for a close follow-up. Sentinel node biopsy is performed investigationally. Modified radical neck dissection is the gold standard for cN+ neck. For patients with multiple node metastases or extracapsular spread, postoperative radiotherapy or chemoradiotherapy is recommended, with the lymph nodes situated outside the confines of the radical neck dissection, such as the lingual and retropharyngeal nodes, receiving considerable attention. Targeted therapy for oral cancer is still a relatively new concept, and more studies are needed to confirm the clinical effectiveness of these drugs.
- 1 January 2014
- Published by Japan Society for Oral Tumors in Journal of Japanese Society of Oral Oncology
- Vol. 26 (4) , 132-139
Salvage surgery for recurrent advanced carcinoma (rT3 or rT4) of the oral cavity
- 1 January 2014
- Published by Japan Society for Oral Tumors in Journal of Japanese Society of Oral Oncology
- Vol. 26 (4) , 132-139
Salvage surgery for recurrent advanced carcinoma (rT3 or rT4) of the oral cavity
- 1 January 2014
- Published by Japan Society for Head and Neck Cancer in Toukeibu Gan
- Vol. 40 (1) , 16-22
Selective neck dissection for oral squamous cell carcinoma
- 1 January 2014
- Published by Japan Society for Head and Neck Cancer in Toukeibu Gan
- Vol. 40 (1) , 16-22
Selective neck dissection for oral squamous cell carcinoma
- 1 May 2013
- Published by Elsevier in Oral Oncology
- Vol. 49, S130
PP106
- 1 May 2013
- Published by Elsevier in Oral Oncology
- Vol. 49, S74
OP186
- 1 May 2013
- Published by Elsevier in Oral Oncology
- Vol. 49, S55
OP131
- 1 January 2012
- Published by Japan Society for Oral Tumors in Journal of Japanese Society of Oral Oncology
- Vol. 24 (2) , 49-54
A case of massive calcifying cystic odontogenic tumor occupying the maxillary sinus and nasal cavity
- 1 January 2012
- Published by Japan Society for Oral Tumors in Journal of Japanese Society of Oral Oncology
- Vol. 24 (2) , 49-54
A case of massive calcifying cystic odontogenic tumor occupying the maxillary sinus and nasal cavity